Relmada Therapeutics Faces Delisting Concerns

Ticker: RLMD · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1553643

Relmada Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyRelmada Therapeutics, Inc. (RLMD)
Form Type8-K
Filed DateJul 23, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory-filing

TL;DR

Relmada might get kicked off the exchange. Big trouble.

AI Summary

Relmada Therapeutics, Inc. filed an 8-K on July 23, 2025, to report a notice of delisting or failure to meet continued listing requirements. The company, formerly known as Camp Nine, Inc., is incorporated in Nevada and has its principal executive offices in Coral Gables, Florida.

Why It Matters

This filing indicates potential issues with Relmada Therapeutics' ability to remain listed on a stock exchange, which could significantly impact its stock price and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation as a publicly traded entity.

Key Players & Entities

  • RELMADA THERAPEUTICS, INC. (company) — Registrant
  • Camp Nine, Inc. (company) — Former company name
  • Nevada (jurisdiction) — State of incorporation
  • Coral Gables, FL (location) — Address of principal executive offices

FAQ

What is the specific reason for Relmada Therapeutics' potential delisting?

The filing states it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,' but does not detail the specific rule or standard not met.

When was this notice filed with the SEC?

The filing was made on July 23, 2025, reporting an event as of July 22, 2025.

What was Relmada Therapeutics' former name?

Relmada Therapeutics, Inc. was formerly known as Camp Nine, Inc.

Where are Relmada Therapeutics' principal executive offices located?

The principal executive offices are located at 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134.

What is the company's IRS Employer Identification Number?

The IRS Employer Identification Number for Relmada Therapeutics, Inc. is 45-5401931.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding RELMADA THERAPEUTICS, INC. (RLMD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.